Main Sector
Pharma (fully integrated)
Subsectors
Antibodies
Anti-infectives
Gene therapy
Nucleic acid drugs
Peptides
Proteins
Vaccines
Indications
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
External causes of morbidity and mortality / traumatology
Products
In development: 125
On the market: 23
Description
Boehringer Ingelheim International GmbH is a company focused on developing and manufacturing medicines for human and animal health. Its Human Pharma business focuses on therapeutic areas including cardiovascular and metabolic diseases, oncology, respiratory diseases, immunology, mental health and retinal diseases, while its Animal Health business develops vaccines, therapeutics and parasite-control products for pets, horses and livestock. The company also provides biopharmaceutical development...
